Biphenyl compounds useful as muscarinic receptor antagonists
This invention provides compounds of formula I: wherein a, b, c, d, m, n, p, s, t, W, Ar 1 , R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , and R 8 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.
1. A compound of the formula:
2. A compound of the formula:
or a pharmaceutically acceptable salt thereof.
3. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of the formula:
or a pharmaceutically acceptable salt thereof.
4. A method of treating a pulmonary disorder in a patient, the method comprising administering to the patient a compound of claim 1 or 2 ; or a pharmaceutical composition of claim 3 ; wherein the pulmonary disorder is chronic obstructive pulmonary disease or asthma.
5. The method of claim 4 , wherein the pulmonary disorder is chronic obstructive pulmonary disease.
6. The method of claim 4 , wherein the pulmonary disorder is asthma.
7. A method of producing bronchodilation in a patient, the method comprising administering to the patient a bronchodilation-producing amount of a compound of claim 1 or 2 ; or a pharmaceutical composition of claim 3 .